Browsing Tag

PRNewswire

63467 posts
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology

MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology

SUZHOU, China, Jan. 2, 2024 /PRNewswire/ — MediLink Therapeutics ("MediLink"), announced today that…
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca

Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca

NATICK, Mass., Jan. 2, 2024 /PRNewswire/ — Allorion Therapeutics ("Allorion"), a US…
Artificial Intelligence Driving Quality Control Machine Vision Market to US.2 Billion by 2028

Artificial Intelligence Driving Quality Control Machine Vision Market to US$7.2 Billion by 2028

NEW YORK, Jan. 2, 2024 /PRNewswire/ — Machine Vision (MV) Solutions for quality…
JJ's House Joins Forces with Sisters in the Fight Breast Cancer Foundation to Make Survivors Feel Beautiful

JJ's House Joins Forces with Sisters in the Fight Breast Cancer Foundation to Make Survivors Feel Beautiful

NEW YORK, Jan. 2, 2024 /PRNewswire/ — JJ’s House, the renowned global online…
Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease

Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease

LOS ANGELES, Jan. 2, 2024 /PRNewswire/ — A recent study published in…
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024

YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024

SHANGHAI, Jan. 2, 2024 /PRNewswire/ — YolTech Therapeutics, a biotech company developing…